期刊文献+

冠心病介入诊疗对比剂应用专家共识 被引量:65

Expert consensus of contrast applying in intervention of coronary artery disease
下载PDF
导出
摘要 1 引言 随着血管造影和经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)技术的发展,对比剂的使用越来越广泛,其安全使用和合理选择也日益受到关注.鉴于此,共识工作小组通过对现有循证医学证据的系统性回顾,并结合专家的临床实践经验,共同制定了此共识,以规范并指导对比剂的临床使用.
出处 《中国心血管病研究》 CAS 2010年第12期881-889,共9页 Chinese Journal of Cardiovascular Research
  • 相关文献

参考文献49

  • 1Contrast Media in Diagnostic Radiology.Pettersson H.The NICER Centennial Book 1995:A Global Textbook of Radiology.The NICER Institute,1995:115-141.
  • 2无.对比剂使用指南(第1版)[J].中华放射学杂志,2008,42(3):320-325. 被引量:72
  • 3Yamaguchi K,Katayama H,Takashima T,et al.Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan:evaluation of pretesting.A report from the Japanese Committee on the Safety of Contrast Media.Radiology,1991,178:363-367.
  • 4《中华人民共和国药典临床用药须知(2005年版)》.
  • 5Klein LW,Sheldon MW,Brinker J,et al.The use of radiographic contrast media during PCI:a focused review:a position statement of the Society of Cardiovascular Angiography and Interventions.Catheter Cardiovasc Interv,2009,74:728-746.
  • 6ESC Guidelines for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes.Chapter Contrast-Induced Nephropathy.Bassand et al.Eur Heart,2007,28:1598-1660.
  • 7中国医师协会心血管内科医师分会,中国医师协会循证医学专业委员会,中国老年学学会心脑血管病专业委员会.心血管疾病防治指南和共识2009.北京:人民卫生出版社,2009.
  • 8Singh J,Daftary A.Iodinated contrast media and their adverse reactions.J Nucl Med Technol,2008,36:69-74.
  • 9Nash K,Hafeez A,Hou S.Hospital-acquired renal insufficiency.Am J Kidney Dis,2002,39:930-936.
  • 10European Society of Urogential Radiology.Guidelines on Contrast Media.Version 6.0,2007.

二级参考文献38

  • 1CHANCE研究组.无保护左主干病变支架置入术预后及影响因素的分析——中国无保护左主干病变支架置入术注册(CHANCE)研究[J].中华心血管病杂志,2005,33(3):210-215. 被引量:19
  • 2李彪,齐海梅,裕东洁,姚稚明,汤天清,赵洪山,褚德发,吴华.Cockcroft-Gault公式和简化MDRD公式估算老年人肾功能准确性的比较研究[J].中华老年医学杂志,2007,26(2):97-100. 被引量:19
  • 3Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿(译),David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志(中文版),2007,26(3):131-139. 被引量:59
  • 4Yamaguchi K, Katayama H, Takashima T, et al. Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media. Radiology, 1991, 178:363-367.
  • 5Widmark JM. Imaging-related medications: a class overview. Proc (Bayl Univ Med Cent), 2007, 20:408-417.
  • 6Thomsen HS, Morcos SK. Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines. Eur Badiol, 2006,16:1835-1840.
  • 7Al Ghonaim M, Pannu N. Prevention and treatment of contrastinduced nephropathy. Tech Vase lnterv Radiol, 2006, 9:42-49.
  • 8McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol, 2006, 98 :SK-13K.
  • 9McCuUough P. Outcomes of contrast-induced nephropathy: experience in patientsundergoing cardiovascular intervention. Catheter Cardiovasc lnterv, 2006, 67:335-343.
  • 10Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrastinduced nephropathy..lAMA, 2006, 295:2765-2779.

共引文献616

同被引文献586

引证文献65

二级引证文献265

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部